|
|
 |
|
|
|
| |
|
Electroconvulsive
Therapy - MECTA Corporation
spECTrum 5000M™
More details: www.mectacorp.com (After viewing this website, please close your browser window to return to Ultracare)
|
| |
|
|
|
The popular spECTrum 5000M™ offers dosing simplicity with one single Stimulus Intensity knob. This varies Frequency and Duration simultaneously, to control Energy and Charge. For those used to a single stimulus knob, the 5000M™ model is the best option in dosing flexibility, while retaining parameters that maximize efficacy and reduce side effects for the patient. The spECTrum ULTRABRIEF© (0.3 ms) pulse width settings and titration tables are included with all MECTA devices.
The base unit includes a choice of two channels of EEG or/and one EEG/ECG arrangement. Add up to four more channels of monitoring for four channels of EEG, one ECG and one Optical Motion Sensor (OMS). EEG Data Analysis, Remote Monitor Software©, MECTA RMS MANAGER© and MECTA EMR© software options may be added for a fully featured device.
Individualize patient treatments for safety and effectiveness with the 5000’s nine menu options: Main, Patient Data, Date & Time, LCD Traces, LCD Gains, Chart Traces, Chart Options, EEG Data and the Parameter Selection menus. One menu display is available in the 4000 models. The LCD touch screen provides the user with an easy interface to set menu options.
The new 5000 models have been enhanced with lighter-weight RoHS (lead-free) cases that provide enhanced durability (3 lbs. lighter). The new robust handle ensures easy repositioning. Touch screen advanced technology offers increased sensitivity and clarity.
MECTA devices also include extensive redundant hardware and software testing to verify that they are operating correctly. The safety of these devices is unparalleled, and as such these devices are an advance that dramatically impact the safety and effectiveness of the ECT treatments.
|
| Best option: |
For hospitals, clinicians and researchers who desire optimal functionality and features with the most ease of use |
| One treatment knob for simplicity in 1% steps. Vary Frequency and Duration simultaneously, to control Energy and Charge |
| When up to six channels of real-time physiological monitoring and EEG Data Analysis are needed to provide the clinician with additional patient information |
| When enhanced data capture is required either through physiological monitoring or recording treatment and/or medical information |
| Efficacious: |
spECTrum ULTRABRIEF© (0.3 ms) option with up to sixteen therapeutic treatment parameters |
| Intuitive: |
Nine visual, easy to use menus accessed by the LCD touch screen to individualize patient treatments. No hard to find menus |
| Portable: |
New enhanced, lighter-weight RoHS (lead-free) case for a smaller footprint and more robust handle |
| Safe: |
Extensive regulatory agency approvals worldwide U.S. (UL); Canada (CSA, Health Canada 8 Approvals, #1537, #62578, #62576); European Union, TUV (EN ISO 13485:2003+AC:2007; CMDCAS ISO 13485:2003; EC
93/42/EEC Annex 11, Article 3); Korea (KFDA); Australia (TGA) |
|
| |
|
|
spECTrum 5000Q®
More details: www.mectacorp.com (After viewing this website, please close your browser window to return to Ultracare)
|
| |
|
|
|
The spECTrum 5000Q® is MECTA’s top-selling device. It offers maximum flexibility to treat with four individual parameter sets of Pulse Width, Frequency, Duration and Current. The treatment dosage is set using the four knobs beneath the LCD touch screen so that the user can easily see and quickly choose the best treatment option to maximize efficacy and reduce side effects. The spECTrum ULTRABRIEF© (0.3 ms) pulse width settings and titration tables are included with all MECTA devices.
The base unit includes a choice of two channels of EEG or/and one EEG/ECG arrangement. Add up to four more channels of monitoring for four channels of EEG, one ECG and one Optical Motion Sensor (OMS). EEG Data Analysis, Remote Monitor Software©, MECTA RMS MANAGER© and MECTA EMR© software options may be added for a fully featured device.
Individualize patient treatments for safety and effectiveness with the 5000’s nine menu options: Main, Patient Data, Date & Time, LCD Traces, LCD Gains, Chart Traces, Chart Options, EEG Data and the Parameter Selection menus. One menu display is available in the 4000 models. The LCD touch screen provides the user with an easy interface to set menu options.
The new 5000 models have been enhanced with lighter-weight RoHS (lead-free) cases that provide enhanced durability (3 lbs. lighter). The new robust handle ensures easy repositioning. Touch screen advanced technology offers increased sensitivity and clarity.
MECTA devices also include extensive redundant hardware and software testing to verify that they are operating correctly. The safety of these devices is unparalleled, and as such these devices are an advance that dramatically impact the safety and effectiveness of the ECT treatments.
|
| Best option: |
For hospitals, clinicians and researchers who desire the optimal functionality and the features of the psychiatric field's top-selling ECT device |
| Where maximum flexibility and the widest range of treatment parameters is desired for reduction of side-effects |
| When up to six channels of real-time physiological monitoring and EEG Data Analysis are needed to provide the clinician with additional patient information |
| When enhanced data capture is required either through physiological monitoring or recording treatment and/or medical information |
| Efficacious: |
spECTrum ULTRABRIEF© (0.3 ms) option with up to sixteen therapeutic treatment parameters |
| Intuitive: |
Nine visual, easy to use menus accessed by the LCD touch screen to individualize patient treatments. No hard to find menus |
| Portable: |
New enhanced, lighter-weight RoHS (lead-free) case for a smaller footprint and more robust handle |
| Safe: |
Extensive regulatory agency approvals worldwide U.S. (UL); Canada (CSA, Health Canada 8 Approvals, #1537, #62578, #62576); European Union, TUV (EN ISO 13485:2003+AC:2007; CMDCAS ISO 13485:2003; EC
93/42/EEC Annex 11, Article 3); Korea (KFDA); Australia (TGA) |
|
| |
|
|
Optional MECTA Device Features
|
| |
|
|
MECTA spECTrum 5000 models are the only ECT devices that can be customized with evidence-based features that optimize the clinician’s ability to treat and monitor the patient. All model 5000 and 4000 devices include the spECTrum ULTRABRIEF© ECT (UB RUL) option, which dramatically minimizes cognitive side effects while maximizing efficacy. Consider any of the five product or three software options when ordering your spECTrum 5000 model to create an ECT device that best meets your clinical needs. 4000 spECTrum models do not include physiological monitoring. We recommend Hand-Held Electrodes for versatility in performing bilateral or unilateral patient treatments.
|
|
|
|
| |
| spECTrum ULTRABRIEF© ECT (0.3 ms) |
| Experience Optimized Patient Outcomes with the Newest Dosing Methodologies |
| |
No other ECT manufacturer provides a proven evidence based methodology as simple and effective to use as the spECTrum ULTRABRIEF© (0.3 ms) ECT feature. This feature was designed and tested at Columbia University in the late 1990s, results were reported46,49 and it was introduced as a feature into MECTA spECTrum ECT devices in July of 2003.
Right unilateral (0.3 ms) ultrabrief six times seizure threshold ECT is equivalent in efficacy to a robust form of bilateral ECT with little sign of cognitive deficit and is simplified by the use of the MECTA spECTrum titration tables. Stimulus dose titration tables are included with each purchase.
No other ECT device implementation of an ultrabrief feature is based on peer reviewed, randomized, double-blind studies. Only spECTrum ULTRABRIEF (0.3 ms) ECT is highly efficient at the lower range, with patients demonstrating seizure thresholds at 5 mC, and can treat the patient across the entire range.
Only MECTA offers hospitals a state of the art ECT device and ultrabrief option that provides the highest benefit by reducing side effects for patients. |
|
| |
|
|
